Tahir Misbah
Maze Therapeutics, Inc. · Chief Financial Officer
Tahir Misbah is listed in filings as Chief Financial Officer at Maze Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 2, 2025, including sale activity. Recent filings connect the profile to Maze Therapeutics, Inc. (MAZE) and IGM Biosciences, Inc. (IGMS). The current snapshot covers public activity from Jun 18, 2024 to Sep 2, 2025. Reported amounts are shown as $5.0M to $1.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1.8k1.5k shares | SellJun 16, 2025 | $1.20 | $1.27 | |
| $9k7.3k shares | SellMar 14, 2025 | $1.23 | $1.27 | |
| $13k1.7k shares | SellDec 16, 2024 | $7.48 | $1.27 | |
| $17k1.5k shares | SellSep 13, 2024 | $11.54 | $1.27 | |
| $12k1.6k shares | SellJun 14, 2024 | $7.58 | $1.27 |